| 產品名稱 | IMM002.69.47.4 |
|---|---|
| 商品貨號 | B190145 |
| Organism | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type | hybridoma:lymphoblast B lymphocyte |
| Product Format | frozen |
| Morphology | lymphoblast |
| Culture Properties | suspension, with some loosely adherent cells |
| Biosafety Level | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease | Cancer |
| Strain | BALB/c |
| Storage Conditions | liquid nitrogen vapor phase |
| Images |  |
| Derivation | Animals were immunized with a pool of plasmacytoma cells (U266, RPMI1860 and OPM) in the left footpad and with K562 chronic myelogenous leukemia cells in the right footpad. The immunization was repeated after 14 days. Lymph node cells were fused Sp2/0 mouse myeloma cells. The antibody is reactive with cell surface membranes of both human myeloma cells and ovarian cancer cells. MA69 detects a distinct band on myeloma membranes binding to a cell surface glycoprotein with an estimated molecular weight of between 78 and 120 kDa. The antibody also recognizes an antigen on ovarian cancer cells with a molecular weight of 76 kDa to 213 kDa. The antigen shares at least one epitope with the multiple myeloma surface antigen. MA69 is not reactive with cell surface membranes of human peripheral blood mononuclear cells, human B cells, neuroblastoma cells, human B cell myelogenic leukemia cells, breast cancer cells, prostate cancer cells, or cervical cancer cells. |
| Comments | Animals were immunized with a pool of plasmacytoma cells (U266, RPMI1860 and OPM) in the left footpad and with K562 chronic myelogenous leukemia cells in the right footpad. The immunization was repeated after 14 days. Lymph node cells were fused Sp2/0 mouse myeloma cells. The antibody is reactive with cell surface membranes of both human myeloma cells and ovarian cancer cells. MA69 detects a distinct band on myeloma membranes binding to a cell surface glycoprotein with an estimated molecular weight of between 78 and 120 kDa. The antibody also recognizes an antigen on ovarian cancer cells with a molecular weight of 76 kDa to 213 kDa. The antigen shares at least one epitope with the multiple myeloma surface antigen. MA69 is not reactive with cell surface membranes of human peripheral blood mononuclear cells, human B cells, neuroblastoma cells, human B cell myelogenic leukemia cells, breast cancer cells, prostate cancer cells, or cervical cancer cells. |
| Complete Growth Medium | The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
|
| Subculturing | Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 1 to 2 x 105 viable cells/mL. Maintain cell density between 5 x 104 and 5 x 105 viable cells/mL Do not exceed 106 cells/ mL. Adherent cells may be removed by shaking the flask. Medium Renewal: Every 2 to 3 days |
| Cryopreservation | Complete growth medium described above supplemented with 5% (v/v) DMSO. Cell culture tested DMSO is available as ATCC Catalog No. 4-X. |
| Culture Conditions | Temperature: 37°C
Atmosphere: Air, 95%; Carbon dioxide (CO2), 5% |
| Isotype | IgG1 kappa |
| Name of Depositor | ImmunoTherapy, Inc. |
| References | Gelber G. Myeloma cell and ovarian cancer cell suface glycoproteins, antibodies thereto, and uses thereof. US Patent 6,376,654 dated Apr 23 2002 Hay, R. J., Caputo, J. L., and Macy, M. L., Eds. (1992), ATCC Quality Control Methods for Cell Lines. 2nd edition, Published by ATCC. Caputo, J. L., Biosafety procedures in cell culture. J. Tissue Culture Methods 11:223-227, 1988. Fleming, D.O., Richardson, J. H., Tulis, J.J. and Vesley, D., (1995) Laboratory Safety: Principles and Practice. Second edition, ASM press, Washington, DC. Biosafety in Microbiological and Biomedical Laboratories, 5th ed. HHS. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Washington DC: U.S. Government Printing Office; 2007. The entire text is available online. |
| 梅經理 | 17280875617 | 1438578920 |
| 胡經理 | 13345964880 | 2438244627 |
| 周經理 | 17757487661 | 1296385441 |
| 于經理 | 18067160830 | 2088210172 |
| 沈經理 | 19548299266 | 2662369050 |
| 李經理 | 13626845108 | 972239479 |
